0001193125-22-161052.txt : 20220526 0001193125-22-161052.hdr.sgml : 20220526 20220526163116 ACCESSION NUMBER: 0001193125-22-161052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220525 ITEM INFORMATION: Other Events FILED AS OF DATE: 20220526 DATE AS OF CHANGE: 20220526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 22970602 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 8-K 1 d353015d8k.htm 8-K 8-K
false 0001668397 0001668397 2022-05-25 2022-05-25

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 25, 2022

 

 

MEDPACE HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-37856   32-0434904

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

5375 Medpace Way

Cincinnati, Ohio 45227

(Address of Principal Executive Offices, and Zip Code)

(513) 579-9911

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock $0.01 par value   MEDP   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 8.01

Other Events.

Increase in Share Repurchase Program

As of May 25, 2022, the Board of Directors (“Board”) of the Company approved an increase of $60 million to the Company’s stock repurchase program. The timing, price and volume of repurchases will be based on market conditions, relevant securities laws and other factors. The stock repurchases may be made from time to time, through solicited or unsolicited transactions in the open market, in privately negotiated transactions or pursuant to a Rule 10b5-1 plan. The program may be discontinued or amended at any time without notice.

Decrease in Shares Outstanding

After April 22, 2022 through May 25, 2022, the Company has repurchased 1,597,007 shares of the Company’s common stock for treasury. These repurchases have resulted in a decrease of approximately 5% of the Company’s outstanding shares of common stock after April 22, 2022. As of May 25, 2022, the Company had 32,065,701 shares of common stock outstanding.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MEDPACE HOLDINGS, INC.
Date: May 26, 2022     By:  

/s/ Stephen P. Ewald

    Name:   Stephen P. Ewald
    Title:   General Counsel and Corporate Secretary
 EX-101.SCH 2 medp-20220525.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 medp-20220525_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 medp-20220525_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
May 25, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001668397
Document Type 8-K
Document Period End Date May 25, 2022
Entity Registrant Name MEDPACE HOLDINGS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-37856
Entity Tax Identification Number 32-0434904
Entity Address, Address Line One 5375 Medpace Way
Entity Address, City or Town Cincinnati
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45227
City Area Code (513)
Local Phone Number 579-9911
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock $0.01 par value
Trading Symbol MEDP
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d353015d8k_htm.xml IDEA: XBRL DOCUMENT 0001668397 2022-05-25 2022-05-25 false 0001668397 8-K 2022-05-25 MEDPACE HOLDINGS, INC. DE 001-37856 32-0434904 5375 Medpace Way Cincinnati OH 45227 (513) 579-9911 false false false false Common Stock $0.01 par value MEDP NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d353015d8k.htm medp-20220525.xsd medp-20220525_lab.xml medp-20220525_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d353015d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d353015d8k.htm" ] }, "labelLink": { "local": [ "medp-20220525_lab.xml" ] }, "presentationLink": { "local": [ "medp-20220525_pre.xml" ] }, "schema": { "local": [ "medp-20220525.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "medp", "nsuri": "http://www.medpace.com/20220525", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d353015d8k.htm", "contextRef": "duration_2022-05-25_to_2022-05-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d353015d8k.htm", "contextRef": "duration_2022-05-25_to_2022-05-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.medpace.com//20220525/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001193125-22-161052-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-161052-xbrl.zip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end